Definition of BB-10901 - NCI Dictionary of Cancer Terms

Page Options

	Quick Links


	Director's Corner Updates from the Director Dictionary of Cancer Terms Cancer-related terms NCI Drug Dictionary Definitions, names, and links Funding Opportunities Research and training NCI Publications Order/download free booklets Advisory Boards and Groups Information, meetings, reports Science Serving People Learn more about NCI Español Información en español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

Quit Smoking Today

	NCI Highlights


	Report to Nation Finds Declines in Cancer Incidence, Death Rates High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E The Nation's Investment in Cancer Research FY 2009 Past Highlights

Search for

Starts with

Contains

In English En español

BB-10901

A substance that combines a monoclonal antibody (huN901) with an anticancer drug (DM1), and is being studied in the treatment of certain cancers, including non-small cell lung cancer. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells.

Previous Definitions:	batracylin, BAY 12-9566, BAY 43-9006, BAY 56-3722, BAY 59-8862
Next Definitions:	BBBD, BBIC, BBR 2778, BBR 3464, BCG